Balk SP - Search Results

1

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer.

Tewari AK, Cheung ATM, Crowdis J, Conway JR, Camp SY, Wankowicz SA, Livitz DG, Park J, Lis RT, Bosma-Moody A, He MX, AlDubayan SH, Zhang Z, McKay RR, Leshchiner I, Brown M, Balk SP, Getz G, Taplin ME, Van Allen EM. Tewari AK, et al. Among authors: balk sp. Cell Rep. 2021 Sep 7;36(10):109665. doi: 10.1016/j.celrep.2021.109665. Cell Rep. 2021. PMID: 34496240 Free article.

2

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP. Taplin ME, et al. Among authors: balk sp. N Engl J Med. 1995 May 25;332(21):1393-8. doi: 10.1056/NEJM199505253322101. N Engl J Med. 1995. PMID: 7723794 Free article.

3

Evidence against T-cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression.

Taplin ME, Frantz ME, Canning C, Ritz J, Blumberg RS, Balk SP. Taplin ME, et al. Among authors: balk sp. Immunology. 1996 Mar;87(3):402-7. doi: 10.1046/j.1365-2567.1996.496571.x. Immunology. 1996. PMID: 8778025 Free PMC article.

4

High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy.

Joyce R, Fenton MA, Rode P, Constantine M, Gaynes L, Kolvenbag G, DeWolf W, Balk S, Taplin ME, Bubley GJ. Joyce R, et al. J Urol. 1998 Jan;159(1):149-53. doi: 10.1016/s0022-5347(01)64039-4. J Urol. 1998. PMID: 9400459

5

Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.

Fenton MA, Shuster TD, Fertig AM, Taplin ME, Kolvenbag G, Bubley GJ, Balk SP. Fenton MA, et al. Among authors: balk sp. Clin Cancer Res. 1997 Aug;3(8):1383-8. Clin Cancer Res. 1997. PMID: 9815822

6

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.

Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, Balk SP. Taplin ME, et al. Among authors: balk sp. Cancer Res. 1999 Jun 1;59(11):2511-5. Cancer Res. 1999. PMID: 10363963

7

Androgen receptor as a target in androgen-independent prostate cancer.

Balk SP. Balk SP. Urology. 2002 Sep;60(3 Suppl 1):132-8; discussion 138-9. doi: 10.1016/s0090-4295(02)01593-5. Urology. 2002. PMID: 12231070 Review.

8

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.

Taplin ME, Balk SP. Taplin ME, et al. Among authors: balk sp. J Cell Biochem. 2004 Feb 15;91(3):483-90. doi: 10.1002/jcb.10653. J Cell Biochem. 2004. PMID: 14755679 Review.

9

AR, the cell cycle, and prostate cancer.

Balk SP, Knudsen KE. Balk SP, et al. Nucl Recept Signal. 2008 Feb 1;6:e001. doi: 10.1621/nrs.06001. Nucl Recept Signal. 2008. PMID: 18301781 Free PMC article. Review.

10

Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.

Bao BY, Chuang BF, Wang Q, Sartor O, Balk SP, Brown M, Kantoff PW, Lee GS. Bao BY, et al. Among authors: balk sp. Prostate. 2008 Jun 1;68(8):839-48. doi: 10.1002/pros.20749. Prostate. 2008. PMID: 18302198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters